Anaphylm™ (dibutepinephrine) sublingual film is the first orally delivered film formulation of epinephrine in clinical development for the emergency treatment of severe allergic reactions, including anaphylaxis.
Developed using both of Aquestive's core technologies (PharmFilm® and AdrenaVerse™), Anaphylm is designed to deliver rapid, effective treatment without the need for injection. Compact, portable, and easy to administer, Anaphylm dissolves on contact and requires no water or swallowing—ideal for real-world emergencies.
